Lacosamide D6
| Product Name | Lacosamide D6 |
|---|---|
| Alternate Names | Lacosamide Stable Isotopes, Stable Isotopes of Lacosamide |
| CAT No. | CS-O-15625 |
| CAS No. | 1219042-77-9 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 256.33 g/mol |
| Mol. For. | C₁₃H₁₂D₆N₂O₃ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Lacosamide |
| Purity | 95% |
| Smileys | O=C([C@@H](COC([2H])([2H])[2H])NC(C([2H])([2H])[2H])=O)NCC1=CC=CC=C1 |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Lacosamide D6 is a deuterated form of lacosamide, a medication used to treat partial-onset seizures in adults with epilepsy. It is a white to off-white crystalline powder that is stable under normal conditions. The deuterated form is used in scientific research for pharmacokinetic and pharmacodynamic studies, as it allows for easy tracking and tracing of the drug in the body.
Lacosamide D6 works by selectively enhancing the slow inactivation of voltage-gated sodium channels, which reduces the excitability of neurons and helps to prevent seizures. It has been shown to be effective in reducing the frequency of seizures in clinical trials and is generally well-tolerated by patients.
Chemically, Lacosamide D6 is a member of the amino acid amide class of antiepileptic drugs. It has a molecular formula of C13H10D6N2O2 and a molecular weight of 240.35 g/mol. It is slightly soluble in water and has a melting point of 174-176°C.
In conclusion, Lacosamide D6 is a deuterated form of lacosamide that is used in scientific research for pharmacokinetic and pharmacodynamic studies. It works by selectively enhancing the slow inactivation of voltage-gated sodium channels, which reduces the excitability of neurons and helps to prevent seizures. It is generally well-tolerated by patients and has shown to be effective in reducing the frequency of seizures in clinical trials.
Get an Instant Quote
Related Compounds
Epi-Lacosamide-d3 | Lacosamide D3 | Lacosamide-13C,D3 |